Mitochondrial Health

Search documents
X @Bitcoin Archive
Bitcoin Archive· 2025-08-16 09:55
RT Bitcoin Archive (@BTC_Archive)💥🎙️DR JACK KRUSE on the ARCHIE PODCAST- Bitcoin, Saylor's pledge, & the Pleb immune system- JFK, CIA, & Media Psyops- Sunlight, Red Light, & Mitochondrial HealthDr Kruse held nothing back in our captivating chat in Prague!Connect with Dr. Jack KruseX: @DrJackKruseWebsite: https://t.co/q5g1m7B6vKPatreon: https://t.co/mnnSBSfCnQTIME STAMPS0:00 - Thoughts on Prague1:25 - The Bitcoin Ethos in Europe4:02 - The Surveillance State and Debanking8:42 - JFK Assassination14:43 - Vaccin ...
X @Bitcoin Archive
Bitcoin Archive· 2025-08-15 20:26
💥🎙️DR JACK KRUSE on the ARCHIE PODCAST- Bitcoin, Saylor's pledge, & the Pleb immune system- JFK, CIA, & Media Psyops- Sunlight, Red Light, & Mitochondrial HealthDr Kruse held nothing back in our captivating chat in Prague!Connect with Dr. Jack KruseX: @DrJackKruseWebsite: https://t.co/q5g1m7B6vKPatreon: https://t.co/mnnSBSfCnQTIME STAMPS0:00 - Thoughts on Prague1:25 - The Bitcoin Ethos in Europe4:02 - The Surveillance State and Debanking8:42 - JFK Assassination14:43 - Vaccine Crises and Bioweapons19:27 - CI ...
Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases
Globenewswire· 2025-06-17 13:04
Core Insights - Northstrive Biosciences Inc. has initiated Phase II of its AI Development Program in collaboration with Yuva Biosciences, focusing on leveraging the MitoNova™ platform to identify small molecule candidates that enhance mitochondrial health in obesity and cardiac diseases [1][6] Company Overview - Northstrive Biosciences Inc. is a biopharmaceutical company under PMGC Holdings Inc., specializing in the development of innovative aesthetic medicines, with its lead asset EL-22 aimed at preserving muscle during weight loss treatments [3] - PMGC Holdings Inc. is a diversified holding company managing a portfolio through strategic acquisitions and investments across various sectors, including three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC [4] Collaboration Details - The collaboration with YuvaBio involves using the MitoNova™ AI platform to virtually screen a large library of drug-like small molecules, predicting which candidates are most likely to promote mitochondrial health [2][6] - YuvaBio will analyze the screening results to identify opportunities for biological validation and compile a list of synthetic compounds aimed at muscle preservation and metabolic health [2]